差分

|[https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)32661-1/fulltext VoyseyM, Merryn, Sue Ann Costa ClemensSAC, Shabir A Madhi, Lily Y Weckx, Pedro M Folegatti, Parvinder K Aley, Brian AngusSA, et al. “Safety Safety and Efficacy efficacy of the ChAdOx1 NCoVnCoV-19 Vaccine vaccine (AZD1222) against SARS-CoV-2: an Interim Analysis interim analysis of Four Randomised Controlled Trials four randomised controlled trials in Brazil, South Africa, and the UK.” The Lancet . 2021;397, no. (10269 (December 8, 2020): 99–11199-111. httpsdoi://doi.org/10.1016/s0140S0140-6736(20)32661-1.]

!Sputnik V|[https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(21)00234-8/fulltext?fbclid=IwAR0Ksw2st-SWQMNykQT30aT098T9owKW4GMqHV2LGO9AsLYzzvPmsvSzZls Logunov DY, Dolzhikova I V, Shcheblyakov D V, et al. Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia. Lancet. 2021;397(10275):671-681. doi:10.1016/s0140-6736(21)00234-8]|-!Johnson&Johnson|[https://www.jnj.com/johnson-johnson-covid-19-vaccine-authorized-by-u-s-fda-for-emergency-usefirst-single-shot-vaccine-in-fight-against-global-pandemic [Press Release] Johnson & Johnson COVID-19 Vaccine Authorized by U.S. FDA For Emergency Use - First Single-Shot Vaccine in Fight Against Global Pandemic. February 27, 2021]